Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

6.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.9K
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

14.6K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
14.6K
Antigens Involved in Adaptive Immunity01:26

Antigens Involved in Adaptive Immunity

1.3K
An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and...
1.3K
Tumor Immunotherapy01:27

Tumor Immunotherapy

1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
Mismatch Repair01:20

Mismatch Repair

6.3K
Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
6.3K
Mismatch Repair01:36

Mismatch Repair

43.5K
Overview
43.5K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Modeling the evolutionary dynamics of clonal hematopoiesis.

Nature genetics·2026
Same author

Extrachromosomal DNA-Driven Oncogene Spatial Heterogeneity and Evolution in Glioblastoma.

Cancer discovery·2025
Same author

The maintenance and de-mixing of extrachromosomal DNA variants in single cells.

bioRxiv : the preprint server for biology·2025
Same author

Extrachromosomal DNA-Driven Oncogene Dosage Heterogeneity Promotes Rapid Adaptation to Therapy in MYCN-Amplified Cancers.

Cancer discovery·2025
Same author

Single-cell mutational burden distributions in birth-death processes.

PLoS computational biology·2025
Same author

Adaptive Therapy Exploits Fitness Deficits in Chemotherapy-Resistant Ovarian Cancer to Achieve Long-Term Tumor Control.

Cancer research·2025

相关实验视频

Updated: Jan 15, 2026

Monitoring the Cancer-Immunity Cycle and Exploring Tumor Microenvironment Dynamics
12:19

Monitoring the Cancer-Immunity Cycle and Exploring Tumor Microenvironment Dynamics

Published on: June 7, 2024

1.9K

癌症-免疫共同进化是由抗原突变积累所决定的.

Long Wang1,2, Christo Morison2, Weini Huang1,2

  • 1Group of Theoretical Biology, Innovation Center for Evolutionary Synthetic Biology School of Life Sciences, Sun Yat-sen University, Guangzhou, China.

eLife
|October 10, 2025
PubMed
概括
此摘要是机器生成的。

癌细胞和免疫细胞共同发展,癌细胞发展出逃生机制. 我们的模型揭示了这些相互作用如何影响瘤的进展,并可以通过遗传测序数据来检测.

关键词:
癌症生物学 癌症生物学癌症 免疫相互作用效应细胞是一种效应细胞.进化生物学是进化的生物学.突变的积累是突变的积累.没有,没有,没有.单细胞突变负担的分布网站频谱频谱的频谱.随机建模 随机建模 随机建模

更多相关视频

Author Spotlight: A Model to Study the Systemic and Local Dynamics of CD8+ T Cells During LN Metastasis
07:45

Author Spotlight: A Model to Study the Systemic and Local Dynamics of CD8+ T Cells During LN Metastasis

Published on: January 26, 2024

2.7K
Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice
07:36

Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice

Published on: June 12, 2021

7.5K

相关实验视频

Last Updated: Jan 15, 2026

Monitoring the Cancer-Immunity Cycle and Exploring Tumor Microenvironment Dynamics
12:19

Monitoring the Cancer-Immunity Cycle and Exploring Tumor Microenvironment Dynamics

Published on: June 7, 2024

1.9K
Author Spotlight: A Model to Study the Systemic and Local Dynamics of CD8+ T Cells During LN Metastasis
07:45

Author Spotlight: A Model to Study the Systemic and Local Dynamics of CD8+ T Cells During LN Metastasis

Published on: January 26, 2024

2.7K
Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice
07:36

Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice

Published on: June 12, 2021

7.5K

科学领域:

  • 免疫学 免疫学 免疫学
  • 计算生物学 计算生物学
  • 癌症研究 癌症研究

背景情况:

  • 免疫系统是对抗癌症的关键防御.
  • 癌细胞可以逃避免疫检测和抑制.
  • 了解瘤免疫动态对于癌症治疗至关重要.

研究的目的:

  • 为了建模癌症和免疫细胞之间的共同进化动态.
  • 调查相互作用如何影响瘤进展和免疫逃避.
  • 为了确定这些动态的遗传特征.

主要方法:

  • 开发了一种基于个体的癌细胞突变积累模型.
  • 癌症和效应性免疫细胞之间的显式模拟的随机相互作用.
  • 对选择的签名分析了测序衍生的总结统计数据.

主要成果:

  • 控制癌症效应细胞相互作用的模型参数决定了瘤结果 (抑制与逃避).
  • 随机效应对于小细胞群的种群动态至关重要.
  • 遗传特征,就像突变负担分布一样,表明共同进化的动态.

结论:

  • 癌症与免疫共同进化显著影响瘤的进展和治疗反应.
  • 基因测序数据可以揭示潜在的瘤免疫相互作用.
  • 该模型提供了关于瘤进化和潜在治疗点的见解.